18F-FDG, 11C-methionine, and 68Ga-Pentixafor PET/CT in patients with smoldering multiple myeloma: imaging pattern and clinical features

X Zhou, A Dierks, O Kertels, M Kircher, A Schirbel… - Cancers, 2020 - mdpi.com
This study aimed to explore the correlation between imaging patterns and clinical features in
patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG …

Quantitative, Dynamic 18F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report

C Sachpekidis, M Türk, A Dimitrakopoulou-Strauss - Diagnostics, 2021 - mdpi.com
We report on a 52-year-old patient with an initial diagnosis of smoldering myeloma (SMM),
who was monitored by means of dynamic and static positron emission …

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

E Zamagni, C Nanni, F Gay, A Pezzi, F Patriarca… - Leukemia, 2016 - nature.com
Identification of patient sub-groups with smoldering multiple myeloma (SMM) at high risk of
progression to active disease (MM) is an important goal. 18F-FDG PET/CT (positron …

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy

B Siontis, S Kumar, A Dispenzieri, MT Drake… - Blood cancer …, 2015 - nature.com
We studied 188 patients with a suspected smoldering multiple myeloma (MM) who had
undergone a positron emission tomography-computed tomography (PET-CT) scan as part of …

Hybrid simultaneous whole-body 2-[18F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results

B Jamet, T Carlier, C Bailly, C Bodet-Milin, A Monnet… - European …, 2023 - Springer
Objectives Mixing diagnostic and prognostic data provided by whole-body MRI (WB-MRI)
and 2-18F-fluorodeoxyglucose (2-[18F] FDG) positron emission tomography (2-[18F] FDG …

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

M Merz, T Hielscher, B Wagner, S Sauer, S Shah… - Leukemia, 2014 - nature.com
Previous studies demonstrated the relevance of focal lesions (FL) in whole-body magnetic
resonance imaging (wb-MRI) at the initial workup of patients with smoldering multiple …

The role of low dose whole body CT in the detection of progression of patients with smoldering multiple myeloma

M Gavriatopoulou, A Βoultadaki, V Koutoulidis… - Blood Cancer …, 2020 - nature.com
Multiple myeloma (MM) is the second most common hematological malignancy,
characterized by plasma cell bone marrow infiltration and end-organ involvement …

Progression to symptomatic multiple myeloma predicted by texture analysis-derived parameters in patients without focal disease at 18F-FDG PET/CT

D Ripani, C Caldarella, T Za, E Rossi… - … Myeloma and Leukemia, 2021 - Elsevier
This retrospective study is focused on the possible clinical implications of texture analysis-
derived PET parameters in patients with smoldering multiple myeloma. Several texture …

Spatial distribution of focal lesions in whole-body MRI and influence of MRI protocol on staging in patients with smoldering multiple myeloma according to the new …

M Wennmann, T Hielscher, L Kintzelé, BH Menze… - Cancers, 2020 - mdpi.com
Simple Summary According to the current SLiM-CRAB-criteria, asymptomatic multiple
myeloma patients who show> 1 focal lesion in MRI are now upstaged to multiple myeloma …

[HTML][HTML] Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma-a potential imaging biomarker for disease prognosis

S Kraus, P Klassen, M Kircher, A Dierks… - Theranostics, 2022 - ncbi.nlm.nih.gov
Beyond being a key factor for tumor growth and metastasis in human cancer, CXC motif
chemokine receptor 4 (CXCR4) is also highly expressed by a number of immune cells …